| Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial A Hildesheim, R Herrero, S Wacholder, AC Rodriguez, D Solomon, ... Jama 298 (7), 743-753, 2007 | 842 | 2007 |
| Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections AC Rodríguez, M Schiffman, R Herrero, S Wacholder, A Hildesheim, ... Journal of the National Cancer Institute 100 (7), 513-517, 2008 | 720 | 2008 |
| Incidence of severe critical events in paediatric anaesthesia (APRICOT): a prospective multicentre observational study in 261 hospitals in Europe W Habre, N Disma, K Virag, K Becke, TG Hansen, M Jöhr, B Leva, ... The Lancet Respiratory Medicine 5 (5), 412-425, 2017 | 682 | 2017 |
| Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the … International Collaboration of Epidemiological Studies of Cervical Cancer International journal of cancer 118 (6), 1481-1495, 2006 | 681 | 2006 |
| Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica R Herrero, W Quint, A Hildesheim, P Gonzalez, L Struijk, HA Katki, ... PloS one 8 (7), e68329, 2013 | 599 | 2013 |
| Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study D Lobo, JM Devys Anaesthesia 77 (1), 110, 2021 | 589* | 2021 |
| Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine AR Kreimer, AC Rodriguez, A Hildesheim, R Herrero, C Porras, ... Journal of the National Cancer Institute 103 (19), 1444-1451, 2011 | 410 | 2011 |
| Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease AK Chaturvedi, HA Katki, A Hildesheim, AC Rodríguez, W Quint, ... The Journal of infectious diseases 203 (7), 910-920, 2011 | 373 | 2011 |
| Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials AR Kreimer, F Struyf, MR Del Rosario-Raymundo, A Hildesheim, ... The Lancet Oncology 16 (7), 775-786, 2015 | 368 | 2015 |
| Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ... The Lancet Oncology 22 (11), 1507-1517, 2021 | 284 | 2021 |
| Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study PE Castle, AC Rodríguez, RD Burk, R Herrero, S Wacholder, M Alfaro, ... Bmj 339, 2009 | 284 | 2009 |
| Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial AR Kreimer, P González, HA Katki, C Porras, M Schiffman, AC Rodriguez, ... The lancet oncology 12 (9), 862-870, 2011 | 262 | 2011 |
| Durable antibody responses following one dose of the bivalent human papillomavirus L1 virus-like particle vaccine in the Costa Rica Vaccine Trial M Safaeian, C Porras, Y Pan, A Kreimer, JT Schiller, P Gonzalez, ... Cancer Prevention Research 6 (11), 1242-1250, 2013 | 245 | 2013 |
| Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and-18 infections M Safaeian, C Porras, M Schiffman, AC Rodriguez, S Wacholder, ... Journal of the National Cancer Institute 102 (21), 1653-1662, 2010 | 214 | 2010 |
| Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica R Herrero, S Wacholder, AC Rodríguez, D Solomon, P González, ... Cancer discovery 1 (5), 408-419, 2011 | 202 | 2011 |
| Evaluation of durability of a single dose of the bivalent HPV vaccine: the CVT trial AR Kreimer, JN Sampson, C Porras, JT Schiller, T Kemp, R Herrero, ... JNCI: Journal of the National Cancer Institute 112 (10), 1038-1046, 2020 | 194 | 2020 |
| Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica R Herrero, A Hildesheim, AC Rodríguez, S Wacholder, C Bratti, ... Vaccine 26 (37), 4795-4808, 2008 | 188 | 2008 |
| Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment A Hildesheim, P Gonzalez, AR Kreimer, S Wacholder, J Schussler, ... American journal of obstetrics and gynecology 215 (2), 212. e1-212. e15, 2016 | 175 | 2016 |
| A study of the impact of adding HPV types to cervical cancer screening and triage tests M Schiffman, MJ Khan, D Solomon, R Herrero, S Wacholder, ... Journal of the National Cancer Institute 97 (2), 147-150, 2005 | 174 | 2005 |
| Evidence for single-dose protection by the bivalent HPV vaccine—review of the Costa Rica HPV vaccine trial and future research studies AR Kreimer, R Herrero, JN Sampson, C Porras, DR Lowy, JT Schiller, ... Vaccine 36 (32), 4774-4782, 2018 | 160 | 2018 |
